Skip to content

Insider · CIK 0001640724

Jarrett Disbrow

officer

Files at AYTU (AYTU BIOPHARMA, INC). First filing Jun 10, 2025, latest Jun 10, 2025.

In brief

Jarrett Disbrow files SEC Form 4 as officer at AYTU (AYTU BIOPHARMA, INC). Since Jun 10, 2025, Jarrett Disbrow has reported 1 open-market buy worth $25k and 0 open-market sells worth $0, the latest filed on Jun 10, 2025.

A track record needs three past buys with six months of prices behind them; Jarrett Disbrow has 0, so none is measured yet.

The newest scored trade: bought $25k of AYTU on Jun 9, 2025, filed Jun 10, 2025, scored 37 (weak).

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$25k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

AYTU: AYTU BIOPHARMA, INC

AYTUOct 9, 2026 · close 2.03

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
37Weak
AYTUbuy 2
AYTU BIOPHARMA, INC
$25k
16,666 shares
+130%+111% from low-26% from high

Transactions

Every row this insider has filed, 5 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jul 28, 2026AYTU
AYTU BIOPHARMA, INC
AGrant or award
Common Stock
+15,000$0.00$076,568Jul 30, 2026
Oct 3, 2025AYTU
AYTU BIOPHARMA, INC
AGrant or award
Common Stock
+19,606$0.00$049,068Oct 7, 2025
Oct 3, 2025AYTU
AYTU BIOPHARMA, INC
AGrant or award
Common Stock
+12,500$0.00$061,568Oct 7, 2025
Jun 9, 2025AYTU
AYTU BIOPHARMA, INC
POpen-market purchase
Common Stock
+16,666$1.50$25k29,462Jun 10, 2025
Nov 6, 2024AYTU
AYTU BIOPHARMA, INC
AGrant or award
Employee Stock Option (Right to Buy)derivative
+7,000$0.00$07,000Nov 8, 2024

Questions about Jarrett Disbrow

Answered from the filings on this page, as of the latest one.

Is Jarrett Disbrow buying or selling?

Not in the last 12 months. Jarrett Disbrow's latest open-market trade on SEC Form 4 was bought $25k of AYTU on Jun 9, 2025.

How did Jarrett Disbrow's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jarrett Disbrow has 0.

Where does Jarrett Disbrow file Form 4?

Jarrett Disbrow has filed Form 4 at AYTU (AYTU BIOPHARMA, INC) as Chief Business Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Jarrett Disbrow: insider trades and track record | InsiderTell